Friday, February 10, 2012
"The source for European pharmaceutical biotechnology news..."
Sponsors
Platinum Sponsors
Blog
Spencer Green
Chairman, GDS International
Chairman, GDS International
Sales and the 'Talent Magnet'
A lot is written about being a ‘Talent Magnet’, either as a company, or as President. It’s all good practice – listen, mentor, reward, provide clear goals and career maps. Good practice for the employer, but what about the employee?25 May 2011
White Papers
Focus Area: HIV/AIDS
HIV/AIDS
HIV/AIDS: Breaking down the wall of silence
Mention HIV/AIDS and the spotlight turns immediately to the plight in Africa and Asia. However, while nobody can deny these continents are now facing the worst of the crisis, Europe cannot afford to ignore the problem on its own doorstep.
No Comments
Taking a role in HIV therapy
The standard of care for the treatment of HIV-1 infection is now a regimen of at least three antiretroviral (ARV) drugs, usually two nucleoside reverse transcriptase inhibitors (NRTI) plus a non-nucleoside RTI (NNRTI) or a protease inhibitor (PI).
No Comments
Source: www.ngpharma.eu.com© 2012 GDS Publishing Ltd. All rights reserved.